Choice of rating form for evaluating anxiolytics

Area of Science:

• Psychiatry
• Clinical Pharmacology
• Psychometrics

Background:

• The Hamilton Anxiety Rating Scale (HAM-A) is widely used for anxiety assessment.
• HAM-A's structure, with 89 symptoms across 14 items, presents challenges in anxiolytic studies, including redundancy and inconsistent ratings.
• The lengthy evaluation process of HAM-A is time-consuming for frequent patient monitoring during pharmacotherapy.

Purpose of the Study:

• To introduce and evaluate the Wilcoxon Anxiety Rating Scale (WARS) as a tool for assessing anxiety symptoms in anxiolytic research.
• To highlight WARS's advantages over HAM-A in terms of simplicity, sensitivity, and efficiency for clinical trials.

Main Methods:

• The WARS was specifically designed to quantify anxiety symptoms relevant to anxiolytic studies.
• WARS comprises 12 one-word items covering key psychic and somatic anxiety symptoms.
• Medication side effects are rated separately, enhancing focus on therapeutic changes.

Main Results:

• WARS is designed to be more sensitive in detecting therapeutic changes in anxiety.
• Its simple, unambiguous format allows for accurate and effortless completion.
• WARS streamlines the assessment process compared to the more cumbersome HAM-A.

Conclusions:

• The WARS is a practical and effective instrument for evaluating anxiety in the context of anxiolytic drug studies.
• WARS offers a more efficient and sensitive alternative to the HAM-A for clinical research on anxiety pharmacotherapy.